Under the expansion, patients will receive a genetic test analyzing DNA from a blood or saliva sample to detect changes or mutations that increase risk of cancer. Licensed genetic counselors will then work with patients to review the results and their medical and family history during clinic and follow-up appointments, according to a Dec. 3 system news release.
Genetic testing has been offered at Fox Chase for over 20 years.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
